This presentation is based on the topic of Buccal drug delivery system. This is the controlled released drug delivery systeme in this delivery system the drug are entrapped in the polymer matrix and released at contolled rate or optimum rate which gives the therapeutic effect.
1. Presented by Under The Guidance
Khan Ramiz V Prof. S. Talele
M. Pharm (1st year)
Dept. of Pharmaceutics
SIPS 1
2. INTRODUCTION
BUCCAL DRUG DELIVERY SYSTEM (NDDS)
It is defined as the drug deliver through the buccal
mucosa of oral cavity is called as BDDS. The buccal
mucosa lines the inner cheek
In biological term, the product is places between
upper gingiva (gums) & cheek to treat local systemic
conditions.
2
3. Advantages
Avoid first pass metabolism
Avoid acid/Enzyme metabolism
Permeation is faster with respect to skin & TDDS
Large surface area with respect to sub-lingual mucosa
Good patient compliance with respect to parental
Easy administration & removal in case of toxicity
For unconscious or conatuse patients
3
4. Disadvantages
Drug with bitter taste or irritant to mucosa or having
noxious smell
Not for children
Eating & drinking difficulty
Salivary erosion & it may enter GIT & choke esophagus
Less surface area than skin
Drug unstable at Buccal pH (6.5 to 7)
4
6. Environment of Buccal Mucosa
The cells of the oral epithelia are surrounded by an
intercellular ground substance, mucus.
The oral cavity is marked by the presence of saliva
produced by the salivary glands.
Mucus which is secreted by the major and minor
salivary glands as part of saliva
6
7. Mechanism
The bioadhesion mainly depends upon nature of
bioadhesive polymer
First stage involves an intimate contact between a
bioadhesive and a membrane
Second stage Involves penetration of the bioadhesive
into tissue
Drug release
Bypasses first pass metabolism
Enters systemic circulation
7
9. IDEAL CHARACTERISTICS OF BDDS
Molecular size 74-100 Daltons.
Molecular weight 200-500g/mol
Drug should be hydrophilic/hydrophobic in nature
Drug should be stable in buccal pH (6.4-7.2)
Drug should be odourless
Drug which are absorbed only by passive diffusion
9
10. Formulation of BDDC
The basic components of buccal drug delivery system
Drug substance
Permeation enhancers
Bioadhesive polymers
Backing membrane
10
11. Drug substance
Dose of the drug should be small
Half life between 2-8 hours
Exhibit first pass metabolism
Absorption should be passive when given orally
Ex:
1. Nicotine
2. Nifedipine
3. Propranolol
4. Diclofenac sodium
11
12. Permeation enhacers
The substance added to pharmaceutical formulation in
order to increase the membrane permeation rate or
absorption rate of co-administered drug.
Ex:
Sodium lauryl sulfate
Bile salt :sodium glycodeoxycholate, sodium
glycocholate
12
13. Bioadhesive Polymers
Polymers used in matrix devices in which the drug in
embedded in the polymer matrix, which controls the
duration of release of drugs.
IDEAL CHARACTERISTICS
Should be inert and compatible with the environment
Non-toxic absorbable from the Mucous layer.
Site specificity
Not decompose on storage
Easily available in the market
Economical
13
15. Backing membrane
Ability to attachment of adhesive device to mucus
membrane
Inert in nature and impermeable to the drug
Such impermeable membrane prevent drug loss and
good patient compliances
Ex: Carbopol, magnesium stearate, polycarbopol
15
18. Types of buccal formulation
Buccal Tablets
Buccal Patches and Films
Buccal Semisolid (Ointment and gels)
Buccal Powder
18
19. Uses of Buccal delivery
The oral cavity can be used for local and systemic
therapy.
Local therapy would be the treatment of oral infections,
dental caries, mouth ulcers, stomatitis , gingivitis etc.
The buccal route is of particular interest with regard to
the systemic delivery of small molecules that are
subjected to first pass metabolism
19
20. Evaluation of Buccal patch
Surface pH : buccal patches are left to swell for 2 hrs on the
surface of an agar plate. The surface pH is measured by
means of a pH paper placed on the surface o the swollen
patch.
Thickness measurement : The thickness of each film is
measured at five different location (center and four corners)
using an electronic digital micrometer.
Swelling study :
Folding endurance : The folding endurance of patches is
determined by repeatedly folding 1 patch at the times without
breaking
20
21. Thermal analysis study : Thermal analysis study is
performed using differential scanning calorimeter (DSC)
Morphological characterization :
Morphological characters are studied by using
scanning electron microscope (SEM)
21
22. Conclusion
The Buccal mucosa offers several advantages for
controlled drug delivery for extended periods of time.
The mucosa is well supplied with both vascular and
lymphatic drainage and first pass metabolism in the
liver and pre-systemic elimination in the
gastrointestinal track avoided.
22